The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase III, randomized, double-blind, placebo (Pla)-controlled study of pertuzumab (P) + trastuzumab (H) + docetaxel (D) versus Pla + H+ D in previously untreated HER2-positive locally recurrent/metastatic breast cancer (LR/MBC) (PUFFIN).
 
Binghe Xu
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Wei Li
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Qingyuan Zhang
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Shao Zhimin
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Wang Xiao Jia
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Huiping Li
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Tao Sun
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Yongmei Yin
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Hong Zheng
Research Funding - Roche (Inst)
Other Relationship - Roche
 
Hong Zhang
Employment - Roche
Other Relationship - Roche
 
Tiffanie Chan
Employment - Genentech; Nektar
Stock and Other Ownership Interests - Genentech; Nektar
Travel, Accommodations, Expenses - Genentech
Other Relationship - Roche
 
Guiyuan Lei
Employment - Roche
Other Relationship - Roche
 
Eleonora Restuccia
Employment - Roche
Stock and Other Ownership Interests - Roche
Other Relationship - Roche